
6,8-Diprenylnaringenin
CAS No. 68236-11-3
6,8-Diprenylnaringenin( Lonchocarpol A | Senegalensin )
Catalog No. M29274 CAS No. 68236-11-3
6,8-Diprenylnaringenin is a natural product from hop Humulus lupulus. 6,8-Diprenylnaringenin is a breast cancer resistance protein(BCRP) inhibitor with some estrogenicity.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product Name6,8-Diprenylnaringenin
-
NoteResearch use only, not for human use.
-
Brief Description6,8-Diprenylnaringenin is a natural product from hop Humulus lupulus. 6,8-Diprenylnaringenin is a breast cancer resistance protein(BCRP) inhibitor with some estrogenicity.
-
Description6,8-Diprenylnaringenin is a natural product from hop Humulus lupulus. 6,8-Diprenylnaringenin is a breast cancer resistance protein(BCRP) inhibitor with some estrogenicity.(In Vitro):6,8-Diprenylnaringenin inhibits ABCG2-mediated efflux of Mitoxantrone, and 3H-Methotrexate transport with an IC50 of 0.41 μM in HEK293 cells.
-
In Vitro——
-
In Vivo——
-
SynonymsLonchocarpol A | Senegalensin
-
PathwayMembrane Transporter/Ion Channel
-
TargetBCRP
-
RecptorBCRP
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number68236-11-3
-
Formula Weight408.5
-
Molecular FormulaC25H28O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)=CCc1c(O)c(CC=C(C)C)c2O[C@@H](CC(=O)c2c1O)c1ccc(O)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog



related products
-
Brevianamide F
A naturally occurring 2,5-diketopiperazine that possess interesting breast cancer resistance protein (BCRP) inhibitory activity.
-
YHO-13177
YHO-13177 is a acrylonitrile derivative and active form of YHO-13351 that can specifically reverse BCRP/ABCG2-mediated drug resistance in vitro and in vivo.
-
KS-176
A potent and selective inhibitor of BCRP multidrug transporter with IC50 of 0.59 and 1.39 uM in Pheo A and Hoechst 33342 assays, respectively.